SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mimedx Group, Inc. – ‘10-K’ for 12/31/16 – ‘EX-101.SCH’

On:  Wednesday, 3/1/17, at 4:17pm ET   ·   For:  12/31/16   ·   Accession #:  1376339-17-42   ·   File #:  1-35887

Previous ‘10-K’:  ‘10-K/A’ on 2/22/17 for 12/31/15   ·   Next:  ‘10-K’ on 3/17/20 for 12/31/18   ·   Latest:  ‘10-K’ on 2/28/24 for 12/31/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/01/17  Mimedx Group, Inc.                10-K       12/31/16   96:9.2M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    885K 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     78K 
 3: EX-3.2      Articles of Incorporation/Organization or Bylaws    HTML     91K 
 4: EX-21.1     Subsidiaries List                                   HTML     25K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML     27K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     28K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     28K 
16: R1          Document and Entity Information                     HTML     53K 
17: R2          Consolidated Balance Sheets                         HTML    115K 
18: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
19: R4          Consolidated Statements of Operations               HTML     73K 
20: R5          Consolidated Statements of Stockholders' Equity     HTML    107K 
21: R6          Consolidated Statements of Cash Flows               HTML    113K 
22: R7          Nature of Business                                  HTML     30K 
23: R8          Significant Accounting Policies                     HTML     72K 
24: R9          Liquidity and Capital Resources                     HTML     31K 
25: R10         Acquisition of Stability Inc.                       HTML    164K 
26: R11         Cash Equivalents and Short Term Investments         HTML     28K 
27: R12         Inventories                                         HTML     39K 
28: R13         Property and Equipment                              HTML     44K 
29: R14         Intangible Assets and Royalty Agreement             HTML     70K 
30: R15         Long-Term Debt                                      HTML     32K 
31: R16         Net Income Per Share                                HTML     57K 
32: R17         Equity                                              HTML    144K 
33: R18         Income Taxes                                        HTML     97K 
34: R19         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     46K 
                Investing and Financing Activities                               
35: R20         401k Plan                                           HTML     31K 
36: R21         Related Party Transactions                          HTML     31K 
37: R22         Commitments and Contingencies                       HTML     66K 
38: R23         Quarterly Financial Data (Unaudited)                HTML     78K 
39: R24         Product Revenue Data                                HTML     45K 
40: R25         Subsequent Events                                   HTML     28K 
41: R26         Schedule II - Valuation and Qualifying Accounts     HTML     73K 
42: R27         Significant Accounting Policies (Policies)          HTML    137K 
43: R28         Acquisition of Stability Inc. (Tables)              HTML    154K 
44: R29         Inventories (Tables)                                HTML     40K 
45: R30         Property and Equipment (Tables)                     HTML     41K 
46: R31         Intangible Assets and Royalty Agreement (Tables)    HTML     70K 
47: R32         Net Income Per Share (Tables)                       HTML     68K 
48: R33         Equity (Tables)                                     HTML    142K 
49: R34         Income Taxes (Tables)                               HTML     93K 
50: R35         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     44K 
                Investing and Financing Activities (Tables)                      
51: R36         Commitments and Contingencies (Tables)              HTML     34K 
52: R37         Quarterly Financial Data (Unaudited) (Tables)       HTML     77K 
53: R38         Product Revenue Data (Tables)                       HTML     39K 
54: R39         Nature of Business (Details)                        HTML     27K 
55: R40         Significant Accounting Policies (Details)           HTML     53K 
56: R41         Liquidity and Capital Resources (Details)           HTML     40K 
57: R42         Acquisition of Stability Inc. - Narrative           HTML     74K 
                (Details)                                                        
58: R43         Acquisition of Stability Inc. - Fair Value of       HTML     40K 
                Stock Consideration (Details)                                    
59: R44         Acquisition of Stability Inc. - Preliminarily       HTML    121K 
                Allocation of Purchase Price (Details)                           
60: R45         Acquisition of Stability Inc. - Intangible Assets   HTML     36K 
                Acquired as Part of Acquisition (Details)                        
61: R46         Acquisition of Stability Inc. - Goodwill            HTML     34K 
                Reconciliation (Details)                                         
62: R47         Acquisition of Stability Inc. - Measurement Period  HTML    117K 
                Adjustments (Details)                                            
63: R48         Acquisition of Stability Inc. - Pro Forma           HTML     32K 
                Information (Details)                                            
64: R49         Cash Equivalents and Short Term Investments         HTML     32K 
                (Details)                                                        
65: R50         Inventories (Details)                               HTML     40K 
66: R51         Property and Equipment (Details)                    HTML     54K 
67: R52         Intangible Assets and Royalty Agreement -           HTML     98K 
                Intangible Asssets Activity Summary (Details)                    
68: R53         Intangible Assets and Royalty Agreement -           HTML     29K 
                Narrative (Details)                                              
69: R54         Intangible Assets and Royalty Agreement - Expected  HTML     42K 
                Future Amortization of Intangible Assets (Details)               
70: R55         Long-Term Debt (Details)                            HTML     47K 
71: R56         Net Income Per Share - Computation of Basic and     HTML     50K 
                Dilutive Net Loss per Share (Details)                            
72: R57         Net Income Per Share - Summary of Antidilutive      HTML     38K 
                Securities (Details)                                             
73: R58         Equity - Narrative (Details)                        HTML     82K 
74: R59         Equity - Activity of Stock Options (Details)        HTML     80K 
75: R60         Equity - Exercise Price Ranges (Details)            HTML     77K 
76: R61         Equity - Summary of Unvested Stock Options          HTML     46K 
                (Details)                                                        
77: R62         Equity - Assumptions (Details)                      HTML     45K 
78: R63         Equity - Summary of Restricted Stock Awards         HTML     51K 
                (Details)                                                        
79: R64         Equity - Recognized Stock-Based Compensation        HTML     36K 
                (Details)                                                        
80: R65         Income Taxes - Deferred Tax Assets and Liabilities  HTML     52K 
                (Details)                                                        
81: R66         Income Taxes - Reconciliation of the Federal        HTML     60K 
                Statutory Income Tax (Details)                                   
82: R67         Income Taxes - Schedule of current and deferred     HTML     51K 
                income tax expense (Benefit) (Details)                           
83: R68         Income Taxes - Narrative (Details)                  HTML     51K 
84: R69         Income Taxes - Reconciliation of unrecognized tax   HTML     31K 
                benefits (Details)                                               
85: R70         Supplemental Disclosure of Cash Flow and Non-Cash   HTML     48K 
                Investing and Financing Activities (Details)                     
86: R71         401k Plan (Details)                                 HTML     38K 
87: R72         Related Party Transactions (Details)                HTML     34K 
88: R73         Commitments and Contingencies - Narrative           HTML     56K 
                (Details)                                                        
89: R74         Commitments and Contingencies - Estimated Annual    HTML     38K 
                Lease, Royalty, and Employment Agreement Expenses                
                (Details)                                                        
90: R75         Quarterly Financial Data (Unaudited) (Details)      HTML     46K 
91: R76         Product Revenue Data (Details)                      HTML     37K 
92: R77         Subsequent Events (Details)                         HTML     33K 
93: R78         Schedule II - Valuation and Qualifying Accounts     HTML     42K 
                (Details)                                                        
95: XML         IDEA XML File -- Filing Summary                      XML    163K 
94: EXCEL       IDEA Workbook of Financial Reports                  XLSX    106K 
10: EX-101.INS  XBRL Instance -- mdxg-20161231                       XML   2.32M 
12: EX-101.CAL  XBRL Calculations -- mdxg-20161231_cal               XML    269K 
13: EX-101.DEF  XBRL Definitions -- mdxg-20161231_def                XML    662K 
14: EX-101.LAB  XBRL Labels -- mdxg-20161231_lab                     XML   1.86M 
15: EX-101.PRE  XBRL Presentations -- mdxg-20161231_pre              XML   1.11M 
11: EX-101.SCH  XBRL Schema -- mdxg-20161231                         XSD    167K 
96: ZIP         XBRL Zipped Folder -- 0001376339-17-000042-xbrl      Zip    257K 


‘EX-101.SCH’   —   XBRL Schema — mdxg-20161231


This Exhibit is an XBRL XML File.


                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<!-- XBRL Document Created with Wdesk from Workiva -->
<!-- -->
<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://mimedx.com/20161231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mdxg="http://mimedx.com/20161231" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
<xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-roles/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-roles-2016-01-31.xsd"/>
<xsd:import namespace="http://fasb.org/us-types/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-types-2016-01-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2016-01-31" schemaLocation="http://xbrl.sec.gov/country/2016/country-2016-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2016-01-31" schemaLocation="http://xbrl.sec.gov/currency/2016/currency-2016-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2016-01-31" schemaLocation="http://xbrl.sec.gov/exch/2016/exch-2016-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/invest/2013-01-31" schemaLocation="http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>
<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20161231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20161231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20161231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mdxg-20161231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="A401KPlan" roleURI="http://mimedx.com/role/A401KPlan">
<link:definition> 2183100 - Disclosure - 401k Plan </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="A401KPlanDetails" roleURI="http://mimedx.com/role/A401KPlanDetails">
<link:definition> 2483401 - Disclosure - 401k Plan (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityInc" roleURI="http://mimedx.com/role/AcquisitionOfStabilityInc">
<link:definition> 2104100 - Disclosure - Acquisition of Stability Inc. </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncFairValueOfStockConsiderationDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncFairValueOfStockConsiderationDetails">
<link:definition> 2404403 - Disclosure - Acquisition of Stability Inc. - Fair Value of Stock Consideration (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncGoodwillReconciliationDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncGoodwillReconciliationDetails">
<link:definition> 2404406 - Disclosure - Acquisition of Stability Inc. - Goodwill Reconciliation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncIntangibleAssetsAcquiredAsPartOfAcquisitionDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncIntangibleAssetsAcquiredAsPartOfAcquisitionDetails">
<link:definition> 2404405 - Disclosure - Acquisition of Stability Inc. - Intangible Assets Acquired as Part of Acquisition (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncMeasurementPeriodAdjustmentsDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncMeasurementPeriodAdjustmentsDetails">
<link:definition> 2404407 - Disclosure - Acquisition of Stability Inc. - Measurement Period Adjustments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncNarrativeDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncNarrativeDetails">
<link:definition> 2404402 - Disclosure - Acquisition of Stability Inc. - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncPreliminarilyAllocationOfPurchasePriceDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncPreliminarilyAllocationOfPurchasePriceDetails">
<link:definition> 2404404 - Disclosure - Acquisition of Stability Inc. - Preliminarily Allocation of Purchase Price (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncProFormaInformationDetails" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncProFormaInformationDetails">
<link:definition> 2404408 - Disclosure - Acquisition of Stability Inc. - Pro Forma Information (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="AcquisitionOfStabilityIncTables" roleURI="http://mimedx.com/role/AcquisitionOfStabilityIncTables">
<link:definition> 2304301 - Disclosure - Acquisition of Stability Inc. (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsAndShortTermInvestments" roleURI="http://mimedx.com/role/CashEquivalentsAndShortTermInvestments">
<link:definition> 2105100 - Disclosure - Cash Equivalents and Short Term Investments </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CashEquivalentsAndShortTermInvestmentsDetails" roleURI="http://mimedx.com/role/CashEquivalentsAndShortTermInvestmentsDetails">
<link:definition> 2405401 - Disclosure - Cash Equivalents and Short Term Investments (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingencies" roleURI="http://mimedx.com/role/CommitmentsAndContingencies">
<link:definition> 2185100 - Disclosure - Commitments and Contingencies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesEstimatedAnnualLeaseRoyaltyAndEmploymentAgreementExpensesDetails" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesEstimatedAnnualLeaseRoyaltyAndEmploymentAgreementExpensesDetails">
<link:definition> 2485403 - Disclosure - Commitments and Contingencies - Estimated Annual Lease, Royalty, and Employment Agreement Expenses (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesNarrativeDetails" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesNarrativeDetails">
<link:definition> 2485402 - Disclosure - Commitments and Contingencies - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="CommitmentsAndContingenciesTables" roleURI="http://mimedx.com/role/CommitmentsAndContingenciesTables">
<link:definition> 2385301 - Disclosure - Commitments and Contingencies (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheets" roleURI="http://mimedx.com/role/ConsolidatedBalanceSheets">
<link:definition> 1001000 - Statement - CONSOLIDATED BALANCE SHEETS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://mimedx.com/role/ConsolidatedBalanceSheetsParenthetical">
<link:definition> 1001501 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfCashFlows">
<link:definition> 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfOperations" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfOperations">
<link:definition> 1002000 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ConsolidatedStatementsOfStockholdersEquity" roleURI="http://mimedx.com/role/ConsolidatedStatementsOfStockholdersEquity">
<link:definition> 1003000 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="DocumentAndEntityInformation" roleURI="http://mimedx.com/role/DocumentAndEntityInformation">
<link:definition> 0001000 - Document - Document and Entity Information </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Equity" roleURI="http://mimedx.com/role/Equity">
<link:definition> 2160100 - Disclosure - Equity </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityActivityOfStockOptionsDetails" roleURI="http://mimedx.com/role/EquityActivityOfStockOptionsDetails">
<link:definition> 2460403 - Disclosure - Equity - Activity of Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityAssumptionsDetails" roleURI="http://mimedx.com/role/EquityAssumptionsDetails">
<link:definition> 2460406 - Disclosure - Equity - Assumptions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityExercisePriceRangesDetails" roleURI="http://mimedx.com/role/EquityExercisePriceRangesDetails">
<link:definition> 2460404 - Disclosure - Equity - Exercise Price Ranges (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityNarrativeDetails" roleURI="http://mimedx.com/role/EquityNarrativeDetails">
<link:definition> 2460402 - Disclosure - Equity - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityRecognizedStockBasedCompensationDetails" roleURI="http://mimedx.com/role/EquityRecognizedStockBasedCompensationDetails">
<link:definition> 2460408 - Disclosure - Equity - Recognized Stock-Based Compensation (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquitySummaryOfRestrictedStockAwardsDetails" roleURI="http://mimedx.com/role/EquitySummaryOfRestrictedStockAwardsDetails">
<link:definition> 2460407 - Disclosure - Equity - Summary of Restricted Stock Awards (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquitySummaryOfUnvestedStockOptionsDetails" roleURI="http://mimedx.com/role/EquitySummaryOfUnvestedStockOptionsDetails">
<link:definition> 2460405 - Disclosure - Equity - Summary of Unvested Stock Options (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="EquityTables" roleURI="http://mimedx.com/role/EquityTables">
<link:definition> 2360301 - Disclosure - Equity (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxes" roleURI="http://mimedx.com/role/IncomeTaxes">
<link:definition> 2165100 - Disclosure - Income Taxes </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://mimedx.com/role/IncomeTaxesDeferredTaxAssetsAndLiabilitiesDetails">
<link:definition> 2465402 - Disclosure - Income Taxes - Deferred Tax Assets and Liabilities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://mimedx.com/role/IncomeTaxesNarrativeDetails">
<link:definition> 2465405 - Disclosure - Income Taxes - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxDetails" roleURI="http://mimedx.com/role/IncomeTaxesReconciliationOfFederalStatutoryIncomeTaxDetails">
<link:definition> 2465403 - Disclosure - Income Taxes - Reconciliation of the Federal Statutory Income Tax (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails" roleURI="http://mimedx.com/role/IncomeTaxesReconciliationOfUnrecognizedTaxBenefitsDetails">
<link:definition> 2465406 - Disclosure - Income Taxes - Reconciliation of unrecognized tax benefits (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesScheduleOfCurrentAndDeferredIncomeTaxExpenseBenefitDetails" roleURI="http://mimedx.com/role/IncomeTaxesScheduleOfCurrentAndDeferredIncomeTaxExpenseBenefitDetails">
<link:definition> 2465404 - Disclosure - Income Taxes - Schedule of current and deferred income tax expense (benefit) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IncomeTaxesTables" roleURI="http://mimedx.com/role/IncomeTaxesTables">
<link:definition> 2365301 - Disclosure - Income Taxes (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreement" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreement">
<link:definition> 2108100 - Disclosure - Intangible Assets and Royalty Agreement </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementExpectedFutureAmortizationOfIntangibleAssetsDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementExpectedFutureAmortizationOfIntangibleAssetsDetails">
<link:definition> 2408404 - Disclosure - Intangible Assets and Royalty Agreement - Expected Future Amortization of Intangible Assets (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementIntangibleAsssetsActivitySummaryDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementIntangibleAsssetsActivitySummaryDetails">
<link:definition> 2408402 - Disclosure - Intangible Assets and Royalty Agreement - Intangible Asssets Activity Summary (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementNarrativeDetails" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementNarrativeDetails">
<link:definition> 2408403 - Disclosure - Intangible Assets and Royalty Agreement - Narrative (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="IntangibleAssetsAndRoyaltyAgreementTables" roleURI="http://mimedx.com/role/IntangibleAssetsAndRoyaltyAgreementTables">
<link:definition> 2308301 - Disclosure - Intangible Assets and Royalty Agreement (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="Inventories" roleURI="http://mimedx.com/role/Inventories">
<link:definition> 2106100 - Disclosure - Inventories </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesDetails" roleURI="http://mimedx.com/role/InventoriesDetails">
<link:definition> 2406402 - Disclosure - Inventories (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="InventoriesTables" roleURI="http://mimedx.com/role/InventoriesTables">
<link:definition> 2306301 - Disclosure - Inventories (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LiquidityAndCapitalResources" roleURI="http://mimedx.com/role/LiquidityAndCapitalResources">
<link:definition> 2103100 - Disclosure - Liquidity and Capital Resources </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LiquidityAndCapitalResourcesDetails" roleURI="http://mimedx.com/role/LiquidityAndCapitalResourcesDetails">
<link:definition> 2403401 - Disclosure - Liquidity and Capital Resources (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LongTermDebt" roleURI="http://mimedx.com/role/LongTermDebt">
<link:definition> 2109100 - Disclosure - Long-Term Debt </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="LongTermDebtDetails" roleURI="http://mimedx.com/role/LongTermDebtDetails">
<link:definition> 2409401 - Disclosure - Long-Term Debt (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NatureOfBusiness" roleURI="http://mimedx.com/role/NatureOfBusiness">
<link:definition> 2101100 - Disclosure - Nature of Business </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NatureOfBusinessDetails" roleURI="http://mimedx.com/role/NatureOfBusinessDetails">
<link:definition> 2401401 - Disclosure - Nature of Business (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomePerShare" roleURI="http://mimedx.com/role/NetIncomePerShare">
<link:definition> 2110100 - Disclosure - Net Income Per Share </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomePerShareComputationOfBasicAndDilutiveNetLossPerShareDetails" roleURI="http://mimedx.com/role/NetIncomePerShareComputationOfBasicAndDilutiveNetLossPerShareDetails">
<link:definition> 2410402 - Disclosure - Net Income Per Share - Computation of Basic and Dilutive Net Loss per Share (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomePerShareSummaryOfAntidilutiveSecuritiesDetails" roleURI="http://mimedx.com/role/NetIncomePerShareSummaryOfAntidilutiveSecuritiesDetails">
<link:definition> 2410403 - Disclosure - Net Income Per Share - Summary of Antidilutive Securities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="NetIncomePerShareTables" roleURI="http://mimedx.com/role/NetIncomePerShareTables">
<link:definition> 2310301 - Disclosure - Net Income Per Share (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ProductRevenueData" roleURI="http://mimedx.com/role/ProductRevenueData">
<link:definition> 2187100 - Disclosure - Product Revenue Data </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ProductRevenueDataDetails" roleURI="http://mimedx.com/role/ProductRevenueDataDetails">
<link:definition> 2487402 - Disclosure - Product Revenue Data (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ProductRevenueDataTables" roleURI="http://mimedx.com/role/ProductRevenueDataTables">
<link:definition> 2387301 - Disclosure - Product Revenue Data (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipment" roleURI="http://mimedx.com/role/PropertyAndEquipment">
<link:definition> 2107100 - Disclosure - Property and Equipment </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipmentDetails" roleURI="http://mimedx.com/role/PropertyAndEquipmentDetails">
<link:definition> 2407402 - Disclosure - Property and Equipment (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="PropertyAndEquipmentTables" roleURI="http://mimedx.com/role/PropertyAndEquipmentTables">
<link:definition> 2307301 - Disclosure - Property and Equipment (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnaudited" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnaudited">
<link:definition> 2186100 - Disclosure - Quarterly Financial Data (Unaudited) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnauditedDetails" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnauditedDetails">
<link:definition> 2486402 - Disclosure - Quarterly Financial Data (Unaudited) (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="QuarterlyFinancialDataUnauditedTables" roleURI="http://mimedx.com/role/QuarterlyFinancialDataUnauditedTables">
<link:definition> 2386301 - Disclosure - Quarterly Financial Data (Unaudited) (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RelatedPartyTransactions" roleURI="http://mimedx.com/role/RelatedPartyTransactions">
<link:definition> 2184100 - Disclosure - Related Party Transactions </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://mimedx.com/role/RelatedPartyTransactionsDetails">
<link:definition> 2484401 - Disclosure - Related Party Transactions (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ScheduleIiValuationAndQualifyingAccounts" roleURI="http://mimedx.com/role/ScheduleIiValuationAndQualifyingAccounts">
<link:definition> 2189100 - Schedule - Schedule II - Valuation and Qualifying Accounts </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="ScheduleIiValuationAndQualifyingAccountsDetails" roleURI="http://mimedx.com/role/ScheduleIiValuationAndQualifyingAccountsDetails">
<link:definition> 2489401 - Schedule - Schedule II - Valuation and Qualifying Accounts (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPolicies">
<link:definition> 2102100 - Disclosure - Significant Accounting Policies </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesDetails">
<link:definition> 2402402 - Disclosure - Significant Accounting Policies (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://mimedx.com/role/SignificantAccountingPoliciesPolicies">
<link:definition> 2202201 - Disclosure - Significant Accounting Policies (Policies) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEvents" roleURI="http://mimedx.com/role/SubsequentEvents">
<link:definition> 2188100 - Disclosure - Subsequent Events </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SubsequentEventsDetails" roleURI="http://mimedx.com/role/SubsequentEventsDetails">
<link:definition> 2488401 - Disclosure - Subsequent Events (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivities" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivities">
<link:definition> 2170100 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesDetails" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesDetails">
<link:definition> 2470402 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Details) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
<link:roleType id="SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesTables" roleURI="http://mimedx.com/role/SupplementalDisclosureOfCashFlowAndNonCashInvestingAndFinancingActivitiesTables">
<link:definition> 2370301 - Disclosure - Supplemental Disclosure of Cash Flow and Non-Cash Investing and Financing Activities (Tables) </link:definition>
<link:usedOn> link:presentationLink </link:usedOn>
<link:usedOn> link:calculationLink </link:usedOn>
<link:usedOn> link:definitionLink </link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="mdxg_AllowanceforObsolescenceMember" name="AllowanceforObsolescenceMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_BoneBankActionMember" name="BoneBankActionMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableDiscount" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuableDiscount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableFairValue" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuedandIssuableFairValue" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationArrangementsGrossProfitMultiplierIfNetSalesTargetNotAchieved" name="BusinessCombinationContingentConsiderationArrangementsGrossProfitMultiplierIfNetSalesTargetNotAchieved" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationLiabilityGrossProfitMarginMultiplier" name="BusinessCombinationContingentConsiderationLiabilityGrossProfitMarginMultiplier" nillable="true" substitutionGroup="xbrli:item" type="xbrli:pureItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationContingentConsiderationMinimumNetSalesForEarnOutPeriodToAvoidReductionInGrossProfitMultiplierAmount" name="BusinessCombinationContingentConsiderationMinimumNetSalesForEarnOutPeriodToAvoidReductionInGrossProfitMultiplierAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransfered" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConsiderationTransfered" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentConsiderationLiabilities" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContingentConsiderationLiabilities" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDebtFreeWorkingCapital" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDebtFreeWorkingCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilitiesNoncurrent" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentDeferredTaxLiabilitiesNoncurrent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFiniteLivedIntangibles" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFiniteLivedIntangibles" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntefiniteLivedIntangibleAssets" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntefiniteLivedIntangibleAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRecognizedIdentifiableAssetsAcquiredGoodwillandLiabilitiesAssumed" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRecognizedIdentifiableAssetsAcquiredGoodwillandLiabilitiesAssumed" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentTangibleAssetsNet" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentTangibleAssetsNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsAccountsReceivable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsAccountsReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsIncomeTaxesReceivable" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCurrentAssetsIncomeTaxesReceivable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebtfreeWorkingCapital" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebtfreeWorkingCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsNet" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTangibleAssetsNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedWorkingCapital" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_ConsultantMember" name="ConsultantMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ContingentRoyaltyToBePaidToLicensor" name="ContingentRoyaltyToBePaidToLicensor" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_CreditAgreementMember" name="CreditAgreementMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_CurrentAssetsandLiabilitiesNet" name="CurrentAssetsandLiabilitiesNet" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_DecreaseInRelatedPartyPayableDueToReturnOrDestructionOfExpiredInventory" name="DecreaseInRelatedPartyPayableDueToReturnOrDestructionOfExpiredInventory" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_DeferredTaxAssetsthatWouldImpactEquitySharebasedCompensation" name="DeferredTaxAssetsthatWouldImpactEquitySharebasedCompensation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element id="mdxg_DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants" name="DefinedBenefitPlanMaximumPreTaxContributionsByPlanParticipants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants" name="DefinedContributionPlanMaximumPercentageOfEligibleWagesDeferredByParticipants" nillable="true" substitutionGroup="xbrli:item" type="num:percentItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount" name="EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_IntangibleAssetsAccumulatedAmortization" name="IntangibleAssetsAccumulatedAmortization" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_LeaseholdImprovementsPaidbyOthersMember" name="LeaseholdImprovementsPaidbyOthersMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LineofCreditFacilityUncommittedIncrementalFacility" name="LineofCreditFacilityUncommittedIncrementalFacility" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="instant"/>
<xsd:element abstract="true" id="mdxg_LiquidityandCapitalResourcesAbstract" name="LiquidityandCapitalResourcesAbstract" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LiquidityandCapitalResourcesTextBlock" name="LiquidityandCapitalResourcesTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LiventaAction437PatentMember" name="LiventaAction437PatentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_LiventaAction701PatentMember" name="LiventaAction701PatentMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_LossContingencyPendingClaimsAllowedforReviewNumber" name="LossContingencyPendingClaimsAllowedforReviewNumber" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="instant"/>
<xsd:element id="mdxg_MaximumEligibleWagesDeferredByParticipantsPerYear" name="MaximumEligibleWagesDeferredByParticipantsPerYear" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumAgeForAdditionalContributionBeyondNormalPlan" name="MinimumAgeForAdditionalContributionBeyondNormalPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumAgeRequireToQualifyForPensionPlan" name="MinimumAgeRequireToQualifyForPensionPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_MinimumServicePeriodRequireToQualifyForPensionPlan" name="MinimumServicePeriodRequireToQualifyForPensionPlan" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_NumberOfShareBasedCompensationPlans" name="NumberOfShareBasedCompensationPlans" nillable="true" substitutionGroup="xbrli:item" type="xbrli:integerItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PatentsinProcessMember" name="PatentsinProcessMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PaymentsforApplicationCostsPatent" name="PaymentsforApplicationCostsPatent" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PaymentsofStockRepurchaseCosts" name="PaymentsofStockRepurchaseCosts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_PeriodOfApprovalMaximum" name="PeriodOfApprovalMaximum" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange1Member" name="PriceRange1Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange2Member" name="PriceRange2Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange3Member" name="PriceRange3Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange4Member" name="PriceRange4Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange5Member" name="PriceRange5Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange6Member" name="PriceRange6Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_PriceRange7Member" name="PriceRange7Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ProceedsFromRelatedPartyPayable" name="ProceedsFromRelatedPartyPayable" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="debit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_ScheduleOfIntangibleAssetsActivityTableTextBlock" name="ScheduleOfIntangibleAssetsActivityTableTextBlock" nillable="true" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_ShareholderDebtMember" name="ShareholderDebtMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member" name="ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_StabilityBiologicsLLCMember" name="StabilityBiologicsLLCMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodSharesExerciseOfWarrants" name="StockIssuedDuringPeriodSharesExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:sharesItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockIssuedDuringPeriodValueExerciseOfWarrants" name="StockIssuedDuringPeriodValueExerciseOfWarrants" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_StockRepurchaseProgramIncreaseDecreaseInAuthorizedAmount" name="StockRepurchaseProgramIncreaseDecreaseInAuthorizedAmount" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_SurgicalBiologicsMember" name="SurgicalBiologicsMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_SurgicalSportsMedicineOrthopedicsSSOMember" name="SurgicalSportsMedicineOrthopedicsSSOMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_UnrecognizedTaxBenefitsthatWouldImpactOtherTaxAccounts" name="UnrecognizedTaxBenefitsthatWouldImpactOtherTaxAccounts" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
<xsd:element id="mdxg_WarrantsTerm" name="WarrantsTerm" nillable="true" substitutionGroup="xbrli:item" type="xbrli:durationItemType" xbrli:periodType="duration"/>
<xsd:element abstract="true" id="mdxg_WoundCareMember" name="WoundCareMember" nillable="true" substitutionGroup="xbrli:item" type="nonnum:domainItemType" xbrli:periodType="duration"/>
<xsd:element id="mdxg_WriteoffofFixedAssets" name="WriteoffofFixedAssets" nillable="true" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType" xbrli:balance="credit" xbrli:periodType="duration"/>
</xsd:schema>


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/17/20  Mimedx Group, Inc.                S-8        12/17/20    5:422K                                   Donnelley … Solutions/FA
11/04/20  Mimedx Group, Inc.                10-Q        9/30/20   79:7.4M
11/02/20  Mimedx Group, Inc.                8-A12B                 1:37K
 8/04/20  Mimedx Group, Inc.                10-Q        6/30/20   71:5.9M
 3/20/17  SEC                               UPLOAD9/28/17    1:173K Mimedx Group, Inc.
Top
Filing Submission 0001376339-17-000042   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 2:51:13.1am ET